IP Library Assignment 042736/0917
Patent Assignment
Reel/Frame 042736/0917

Assignment of Assignor's Interest

Recorded: 2017-06-16 Pages: 4
Assignors
YOMODA, SATOSHI
Executed: 2016-10-31
CHIBA, SHIGEKI
Executed: 2016-10-31
KAWASHIMA, TAKANORI
Executed: 2016-10-31
OKUBO, TOSHIKI
Executed: 2016-10-31
MURATA, KENTA
Executed: 2016-10-31
Assignee
KRACIE PHARMA, LTD.
31-1, KANEBO-MACHI, TAKAOKA-SHI, TOYAMA, 9330856, JAPAN
Covered Property (1)
Anticancer Agent and Side-Effect-Alleviating Agent
Patent: 9,907,852 →
Application: 15/302,863 →
Publication: US 2017/0028065
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 23, 2017
From: TEZUKA, YASUHIRO
To: NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA
Reel/Frame 042466/0849 →
Assignment of Assignor's Interest Jun 16, 2017
From: IKEDA, MASAFUMI; TSUCHIHARA, KATSUYA
To: NATIONAL CANCER CENTER
Reel/Frame 042876/0876 →
Assignment of Assignor's Interest Jun 16, 2017
From: ESUMI, HIROYASU
To: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
Reel/Frame 042876/0879 →
Merger Jun 20, 2024
From: KRACIE PHARMA, LTD.
To: KRACIE HOLDINGS, LTD.
Reel/Frame 067794/0001 →
Change of Name Jun 20, 2024
From: KRACIE HOLDINGS, LTD.
To: KRACIE, LTD.
Reel/Frame 067794/0146 →